Supplementrary Tables.docx (36.73 kB)

Supplementary Tables. Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy.

dataset

posted on 2021-10-25, 10:30 authored by Perry B Shieh, Gary Elfring, Panayiota Trifillis, Claudio Santos, Stuart W Peltz, Julie A Parsons, Susan Apkon, Basil T Darras, Craig Campbell, Craig M McDonald

Supplementary Table 1. Search strategy for Ovid MEDLINE® (1 January 2000 to 30 November 2020).

Supplementary Table 2. Search strategy for Ovid EMBASE® (1 January 2000 to 30 November 2020).

Supplementary Table 3. Primary and post-hoc studies of patients receiving deflazacort or prednisone/prednisolone.

Funding

This research was funded by PTC Therapeutics, Inc., and did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.

History

Usage metrics

Read the peer-reviewed publication

Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy

Journal of Comparative Effectiveness Research

Keywords

deflazacort Duchenne muscular dystrophy meta-analysis nonsense mutation Duchenne muscular dystrophy prednisone prednisolone Neurology and Neuromuscular Diseases

Licence

CC BY-NC-ND 4.0